歯科麻酔薬市場 – 2030年までの世界予測

出版社 MarketsandMarkets
出版年月 2025年5月

Dental Anesthetics Market – Global Forecast To 2030

歯科麻酔薬市場 – 薬剤の種類(リドカイン、メピバカイン、アルチカイン、ブピバカイン、メピバカイン、プリロカイン)、投与経路(局所、注射、シリンジ、針)、エンドユーザー(病院、クリニック、その他)、地域別 – 2030年までの世界予測
Dental Anesthetics Market by Drug Type (Lidocaine, Mepivacaine, Articaine, Bupivacaine, Mepivacaine, Prilocaine), Route of Administration (Topical, Injectable, Syringes, Needles), End User (Hospitals, Clinics, Others), Region – Global Forecast to 2030

本市場調査は、様々なセグメントにわたる歯科麻酔薬市場に焦点を当てています。その目的は、薬剤の種類、投与経路、エンドユーザー、地理的地域など、様々なカテゴリーにおける市場規模と成長の可能性を推定することです。さらに、本調査には、市場の主要プレーヤーの包括的な競合分析と企業プロフィールが含まれています。本分析では、各社の製品ラインナップ、最近の動向、そして市場における主要戦略に関する重要な考察も取り上げています。

The global dental anesthetics market is projected to reach USD 1.80 billion by 2030 from USD 1.48 billion in 2025, at a CAGR of 4.0% during the forecast period.

世界の歯科麻酔薬市場は、予測期間中に年平均成長率4.0%で成長し、2025年の14億8,000万米ドルから2030年には18億米ドルに達すると予測されています。

The global market for dental anesthetics is expanding due to a rising incidence of dental issues, which has led to an increase in dental procedures. Furthermore, there is greater awareness of the importance of oral health and cosmetic dentistry, prompting more individuals to seek dental treatments. Improved income levels and enhanced healthcare infrastructure in many regions make dental care more accessible. Additionally, the growing elderly population is expected to drive up demand for these services. However, during the projected period, challenges such as a shortage of dental practitioners and limited insurance coverage for dental procedures may hinder market growth to some extent.

歯科麻酔薬の世界市場は、歯科疾患の発生率上昇に伴い歯科治療件数が増加していることから拡大しています。さらに、口腔衛生と審美歯科の重要性に対する意識が高まり、歯科治療を受ける人が増えています。多くの地域では、所得水準の向上と医療インフラの整備により、歯科医療へのアクセスが容易になっています。さらに、高齢化人口の増加も、これらのサービスに対する需要を押し上げると予想されています。しかしながら、予測期間中は、歯科医師不足や歯科治療に対する保険適用範囲の狭さといった課題が、市場の成長をある程度阻害する可能性があります。

歯科麻酔薬市場 – 2030年までの世界予測
dental-anesthetics-market-Ecosystem

The prominent players in the global dental anesthetics market are Septodont Holding (France), DENTSPLY SIRONA (US), Pierrel (Italy), Huons Global (South Korea), Normon (Spain), DFL Indústria e Comércio S/A (Brazil), Ultradent Products Inc. (US), Hikma Pharmaceuticals Plc (UK), Clarben Laboratories (Spain), New Stetic S.A (Colombia), Primex Pharmaceuticals (Switzerland), Keystone Industries (US), Centrix, Inc. (US), GC SHOWAYAKUHIN CORPORATION (Japan), DMG America LLC (US), Zeyco (Mexico), Zymeth Pharmaceutical (India), Cetylite, Inc. (US), ICPA Health Products Limited (India), Crosstex International, Inc. (US), Young Innovations, Inc. (US), Mark3 (Cargus International, Inc.) (US), J.Morita Corp. (Japan), Kulzer GmbH (Germany), and Integra Lifesciences Corporation (US).

This report provides insights on the following pointers:

Analysis of key drivers (increasing patient pool for dental treatments, increasing demand for advanced cosmetic dental procedures, and technological advancements in anesthetic delivery), restraints (potential adverse effects), opportunities (rising number of DSOs and growing private equity investments, emerging markets, and growing dental tourism) and challenges (dearth of trained dental practitioners and needle phobia).

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global dental anesthetics market. The report analyzes this market by drug type, route of administration, end user, and region.
  • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global dental anesthetics market.
  • Market Development: Thorough knowledge and analysis of the profitable rising markets by drug type, route of administration, end user, and region.
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of leading players in the global dental anesthetics market.